Is Razumab Injection Price Justified: A Comprehensive Analysis of Cost, Efficacy, and Alternatives
•
5 min read
In 2024, the introduction of biosimilar ranibizumab in India led to a remarkable 94% reduction in the annual treatment cost compared to the innovator drug in 2006. This significant market shift directly impacts patients asking: is Razumab injection price manageable for treating retinal conditions like wet AMD?
